Top Basic Facts You Should Know about Writing Companies

Wazzup Pilipinas!?



Today’s college routine is impossible without using writing help. Check out some basic info about it given in our article.

 

How Much Should Students Pay Someone to Write My Essay and Is It Important?

We guess every college student has lived through tough times when nothing seemed to work well. There are problems with understanding new materials, and the demands of a concrete assignment, or subject. Some folks simply run out of time. All these and other issues negatively effective their rating and drop them from the top to the bottom. Young people want to avoid such cases and commonly ask – How am I supposed to write my essay or any other paper type to enjoy the best grades?

Many students have no idea and so look for various solutions. They leave online cries for help that look like this – Who can do my essay for me? Clever youngsters know about various custom writing services that help to cope with all academic assignments on time and reach the desired quality. In the meanwhile, you have to buy professional aid and it’s not always affordable for common students. Is it worth a try? How much money must be paid? These 2 vital questions are answered in our critical overview. Read on to find out more!

 
What Is the Cost?

First of all, let’s clarify one crucial point related to the issue of – Who will do my essay online? It is about the price you will surely have to pay. When you visit any custom writing website, you need to ask – How much should I pay you to write my papers for me? You surely know that professional aid is offered only for sale. So, what is the price?

It’s hard to answer this question in one sentence. Firstly, there are a lot of writing websites and their price policies may differ from one another. Yet, one can define at least the average cost. It ranges from $9 to $21 per page. No top-rated platform will go below or above this indicator. This indicator is relatively cheap.

Secondly, you need to be sure that the platform is legit and confidential. It must have the necessary permissions to work. It must never reveal any facts about your private data or order to anyone else.

Thirdly, it’s supposed to offer full customization of your essays and other academic assignments. Thus, you will be able to regulate the price according to your finances. When you fill out the application form, provide the next details:

● Quality of your assignment.

● Its type.

● Length.

● Deadline.

You’ll see the final bid. If it exceeds your budget, make fast changes to the application. Every change can lower the price. For example, the most urgent it is, the more fees will be charged. Prolong the deadline to get a cheaper bid and confirm it.

Mind that trustworthy platforms also offer a refund guarantee. It ensures your money. After your helper accepts your terms, he/she is obliged to fulfill them as promises. In case your agreement is violated from the writer’s side, your money will be returned.

 
Reasons to Use Pro Aid

Once we’re done with pricing, let’s get through the reasons why you should purchase professional aid. How and who will write my essays? Always ask this question when you visit any custom writing service to be sure you enjoy all you deserve.

Firstly, you should know that the quality of assistance is always high when you deal with a legit and confidential writing website. Who will do my essays? You will get help from only certified and verified writers who have passed the necessary entry tests and job interviews. Thus, you can be 100% confident that any writer found on a reliable writing website is able to match the highest demands of every educational institution.

When you hire a helper, do not think that he or she can help only with an essay. Pro writers can also assist with completing such a complicated project as a term paper or even a dissertation! Besides, you aren’t obliged to buy academic aid all the time long. There are cases when it can be acquired for free. What are those cases? Check the following opportunities:

● Some platforms offer free online consultations.

● All platforms offer chargeless learning materials – articles, guides, topic lists, samples, etc.

● A plagiarism checkup is always gratis.

● Title pages and reference lists are commonly free of charge as well.

Thus, you may be lucky to get the necessary answers without spending a dollar! You only need to make research to find out which websites offer non-paid conditions and guarantees. Use them to the fullest to enjoy the outcomes you require.

 
Conclusion

Who can do my essays, and what is the price? We guess we have managed to answer these vital questions. It’s up to you to decide what to do with the facts we have provided. We are sure that your choice will be correct.

Contribution rate increase boosts SSS fund life by 22 years

Wazzup Pilipinas!?


The Social Security System (SSS) announced today that an additional 22 years have been added to the SSS fund life with the help of contribution rate increases since 2019.

SSS President and Chief Executive Officer Michael G. Regino explained how after implementing the additional P1,000 pension benefit in 2017, the SSS fund life would have lasted until 2032 only.


However, with the help of gradual contribution rate increases mandated by Republic Act No. 11199 or the Social Security Act of 2018, the fund life was extended by another 12 years or until 2044.


Recently, the latest SSS actuarial valuation has shown that the fund life was boosted by another 10 years to which Regino has credited to the SSS’ efforts to boost its membership and coverage.


The SSS now projects the fund life to be extended until 2054. This means an additional 22 years wherein all SSS members and pensioners can enjoy their various benefits.


Starting January 1, 2023, the SSS will then implement the third step of its four-tier contribution increase. The SSS contribution rate would become 14 percent – up by one (1) percentage point from the current 13 percent.


In the meantime, Regino shared how the SSS is still working towards further extending the fund life in response to its mandate of providing social security protection to its stakeholders which should transcend within generations.

“It is important for us to implement the contribution rate increase together with other social reforms so we could achieve this goal and ensure that we have sufficient funds to provide the short- and long-term benefits, including the immediate financial needs, of our members and pensioners especially in times of contingencies,” Regino added.

Experience, Suitability, critical to public vaccination against Pneumonia in PH, says Local Public Health Expert

Wazzup Pilipinas!?



In observance of the recently concluded World Pneumonia Day last November 12, a local public health expert reinforced that a pneumococcal conjugate vaccine (PCV) should be suitable against local strains and backed up by sufficient real world experience before being introduced in the National Immunization Program (NIP).

According to Dr. Maria Margarita Lota, chair of the Department of Medical Microbiology at the University of the Philippines’ College of Public Health, vaccination is one of the most effective ways to combat pneumonia, one of the leading causes of death in children less than five years old.

“Being a pediatrician, we have to protect our children. As pneumonia continues to be a top cause of morbidity and mortality, we are fortunate that we are in an era where vaccination for many of these infectious diseases, like pneumonia, are available. Aside from proper hygiene and nutrition, vaccination is one of the most effective ways to prevent pneumonia.”


Right PCV against the Right Strains

Dr. Lota gave her expert opinion on factors that should be considered before implementing a PCV under the NIP. Alongside cost-effectiveness and programmatic characteristics, she reinforced that a PCV should be suitable to protect against strains that are prevalent in the Philippines.

“One of the things that we really have to look for when we are considering the inclusion of a particular PCV in the NIP is your serotypes. ‘pag alam natin kung ano yung mga nag-eexist na serotypes in the community, we have to directly target these serotypes, or if not directly, ensure that there are reports of [this PCV] doing cross-protection,” she remarked.

In 2020, the Health Technology Assessment Council (HTAC) of the Department of Health (DOH), which is in charge of appraising health technologies that can be included for public use, recommended the use of PCVs protecting against 11 important strains which accounted for 48% of Invasive Pneumococcal Disease (IPD) cases found in the Philippines, namely: 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.1 The recommendation was based on local surveillance data of the Research Institute of Tropical Medicine (RITM) from 2012-2019.2

“By knowing which serotypes are circulating, kung meron naman ‘yong brands, this can already be used to prevent pneumonia significantly in the country. In the report that was made in 2019 by RITM, 48% of the circulating serotypes in the country can be addressed by currently available PCVs,” she remarked.

On the other hand, Dr. Lota also recognized the urgent need to improve surveillance of circulating strains of pneumonia in the Philippines.

“Different countries have different circulating serotypes. In our anti-microbial resistance

surveillance program, they identified several serotypes causing pneumonia, but the problem with that was that there were low reports of isolates submitted to RITM. This becomes a barrier for us to really understand what are the prevalent serotypes in the country,” said Dr Lota.



Real-world Experience to combat Vaccine Hesitancy

Despite the availability of PCV in the National Immunization Program (NIP), a root cause to the still high number of cases of vaccine preventable diseases can be attributed to parents' hesitancy to vaccinate their children, leading to less infants being brought to health facilities to be vaccinated against diseases like pneumonia.

“Unfortunately, even if we have all of these vaccines against pneumonia available in the NIP, it continues to be a burden of disease in many countries especially in low to middle income countries like the Philippines. The uptake of our vaccines is not very high because of the controversy of the dengue vaccine in 2016. Therefore, less babies are being brought to the health centers, so the consequence will be an increased number of pneumonia cases, one of the vaccine-preventable diseases that could have been prevented.

To address this, Dr Lota highlighted that a PCV should have sufficient experience and accessible real-world evidence before being implemented in the Philippine NIP to address vaccine hesitancy.

“Accessible real-world evidence is connected to vaccine hesitancy. Even if we know that a vaccine can trigger a good immune response (“immunogenicity”), we need to still see if a vaccine is really effective when it is introduced in the community rather than just a sample cohort for instance. This will give confidence to parents that they can actually use this particular vaccine,” said Dr. Lota

As a concrete example, Dr. Lota mentioned that we could learn from the slow acceptance of COVID-19 vaccines when it was first introduced in the Philippines.

“An example of this is your COVID-19 vaccine. In spite of being licensed and approved, many parents were hesitant during its release because it did not have enough data to show to the public. But if you have real-world evidence, which usually comes after the post-marketing, they will have more confidence that, yes, I can use this because it is safe and effective,” she added.

Last October, HTAC released the final priority list of health technology topics that will be assessed for possible inclusion in the Philippine National Formulary (PNF), of which includes PCV.3

Currently, there are three PCVs pre-qualified by the World Health Organization—PCV13 and 2 kinds of PCV10: PHID-CV and SIIL-PCV. The two PCVs that were reviewed by HTAC in 2020—PHID-CV and PCV13—were assessed as suitable to address the 11 important strains in the country.4



Speaker Background

Dr. Maria Margarita M. Lota is an Assistant Professor at the Department of Medical Microbiology. She is a graduate of Bachelor of Science in Public Health at University of the Philippines and pursued her Doctor of Medicine at the University of the East Ramon Magsaysay Medical Center. Further training in Pediatrics was completed at the Philippine General Hospital. Thereafter, she joined as faculty in the College of Public Health. She actively participates in the conduct of medical microbiology courses in the undergraduate and graduate programs. She acts as the lead coordinator for the various microbiology courses in the College of Medicine. Further, she has coordinated several local and international training programs. Her clinical expertise in Pediatrics contributes to her approach in teaching the different infectious diseases which has become her main focus in the field of Microbiology. As a complement to her passion for teaching, she completed her Masters in Health Professions Education at the National Teacher Training Center for the Health Professions of the University of the Philippines Manila. Dr. Lota is a member of the Las Piñas Medical Society and a fellow of the Philippine Pediatric Society.She has done several researches and publications on antimicrobial resistance, tuberculosis and enteric bacteria. Her interest include pediatric microbial infections, vaccinations and antimicrobial resistance. With her experience in the field of Medical Microbiology, she has been invited as speaker to different local and international workshops and conferences.


Source: https://cph.upm.edu.ph/user-profile/116